This report reviews, analyzes and sizes the cell based screening and analysis market. The study uncovers interesting information about key equipment, consumables, reagents, software and services that are marketed to biotech and pharmaceutical companies that are doing drug discovery research.

Large bio-pharma companies have commented at industry meetings that fifty percent of their high throughput compound screening projects in drug discovery involves screening cells. The companies are using cell-based assays for both primary and secondary screening and have taken a great interest in the areas of high content screening and high content analysis.

The report assesses the market and maps the competitors on the market landscape with more than 80 companies identified. The financial section sizes the market and discusses the five-year revenue projection. The market is segmented by major product areas as well as market sub segments. This market is also segmented by major world regions to see the growth or how the market share might change.

Major company alliances, M&As, patents that were issued during the last two years are reviewed and analyzed. Large data tables summarize the alliances, M&As and patents. The alliance table summarizes more than 210 deals. The patent table displays key details of over 340 patents.

This research report is designed for people that include marketers, business development, top executives, investors, VCs, consultants, R&D managers, entrepreneurs and etc. More than 42 detailed tables or figures provide key data about items such as strategic alliances, M&As, market size, segments and the like.

This report includes 28 company profiles that provide the reader a snapshot of the companies’ focus or activities. The provided Internet links help readers access companies’ own web sites for further review.

Table 1	Equipment for Cell Based Screening and Analysis
Table 2	Equipment Competitors by Large, Medium & Small Companies
Table 3	Consumables Competitors by Large, Medium & Small Companies
Table 4	Content Competitors by Large, Medium & Small Companies
Table 5	Services Competitors by Large, Medium & Small Companies
Table 6	Other Competitors by Large, Medium & Small Companies
Table 7	Wide Field vs. Confocal HCS/ HCA Equipment
Table 8	Confocal HCS/ HCA Imaging Equipment Used By Bio-Pharmas
Table 9	Summary of Cell-based M&As & Alliances, 2004 through 2006
Table 10	Summary of Cell-based M&As by Top Acquirers
Table 11	M&As and Alliances, 2006
Table 12	M&As and Alliances, 2005
Table 13	M&As and Alliances for Cell-Based Screening and Analysis, 2004
Table 14	CBA Related IP by No. of New Patents Issued, 2005 & 2006
Table 15	WW Cell-Based Screening-Analysis (CBSA) Market for Bio-Pharma. Drug Discovery & Development (BPDD)
Table 16	WW Market by Major Segments & Revenues
Table 17	WW Market by Major Segments & Shares, 2007 & 2011
Table 18	'Equipment' Segments by Product Type
Table 19	'Consumables' Segments by Type
Table 20	'Content' Segments by Type
Table 21	'Services' Segments by Type
Table 22	The 'Others' Segment
Table 23	CBSA Market by Major Worldwide Regions
Table 24	Market by Major Worldwide Region Share, 2007 & 2011
Table 25	Leading 'Equipment' Vendors by Est. Market Share Rank
Table 26	Leading 'Consumables' Vendors by Est. Market Share Rank
Table 27	Major CBSA Products & Services Segments by Growth Rate
Table 28	'Services' Sub-segments by Growth Rate
Table 29	'Consumables' Sub-segments by Growth Rate
Table 30	'Equipment' Sub-segments by Growth Rate
Table 31	Company Contacts, Web Links and State/Country
Table 32	Patent Data by Technology Type, Company, Patent and Title

List of Illustrations

Figure 1	WW Cell Based Screening and Analysis by Products & Services
Figure 2	Traditional Drug Discovery and Development Paradigm
Figure 3	MDC FLIPR vs. Competing HTS Flash Luminescence Plate Imagers
Figure 4	WW Cell-Based Screening-Analysis (CBSA) Market for Bio-Pharma. Drug Discovery & Development (BPDD)
Figure 5	WW Market by Major Segments & Revenues
Figure 6	WW Market by Major Segments & Shares, 2007 & 2011
Figure 7	'Equipment' Segments by Type
Figure 8	'Consumables' Segments by Type
Figure 9	'Content' Segments by Type
Figure 10	'Services' Segments by Type
Figure 11	The 'Others' Segment
Figure 12	CBSA Market by Major Worldwide Regions
Figure 13	Market by Major Worldwide Region Share, 2007 & 2011
Figure 14	A Typical High Content Screening Solution
Figure 15	Molecular Devices Cell Based Screening Systems
Figure 16	Cellomics Imaging System for High Content Screening and Analysis

Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery Equipment, Technology and Companies, 2006-2011 — January 2007 is 155 pages and is available in English or Japanese languages. Hard Copy edition for $1,495.00 US, a PDF single-departmental license for $2,295.00 US, and a PDF Corporate-Wide License for $2,995.00 US. For more information or to order the report, contact Rob Smith at 408-524-9767 or rsmith@mrgco.com.

Order Form